About OCULOGENEX INC
Oculogenex is a biotech company developing gene therapy to treat macular degeneration and other degenerative retinal diseases. The company has received an SBIR Phase I Grant and has participated in notable events such as the LA BEST Summit and MassChallenge.
Development of gene therapy for macular degenerationResearch and clinical trials for ophthalmic treatmentsParticipation in biotech competitions and events
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to OCULOGENEX INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.